Skin lesions in adult liver transplant recipients: A study of 100 consecutive patients

British Journal of Dermatology

Volumn 154, Issue 5, 2006, Pages 868-872

  Perera, G K ^a   Child, F J ^a   Heaton, N ^a   O'Grady, J ^a   Higgins, E M ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Basal; Immunosuppression; Liver transplant; Skin cancer; Squamous; Sun

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; BACTERIAL INFECTION; BASAL CELL CARCINOMA; DRUG INDUCED CANCER; FACE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; ORGAN TRANSPLANTATION; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RECIPIENT; SKIN CANCER; SKIN DEFECT; SKIN EXAMINATION; SKIN INFECTION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; VIRUS INFECTION;

ADULT; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KERATOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; SKIN DISEASES; SKIN DISEASES, INFECTIOUS; SKIN NEOPLASMS; SUNLIGHT;

EID: 33645811541     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07154.x     Document Type: Article

References (32)

1. Glover MT Deeks JJ Raftery MJ et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997 349 398.
2. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1994 7 99 109.
3. Bouwes Bavinck JN Kootte AMM van der Woude FJ et al. HLA-A11 associated resistance to skin cancer in renal-transplant recipients. N Engl J Med 1990 323 1350.
4. Streilein JW. Immunogenetic factors in skin cancer. N Engl J Med 1991 325 884 6.
5. Behrend M Kolditz M Kliem V et al. Malignancies in patients under long-term immunosuppression after kidney transplantation. Transplant Proc 1997 29 834 5.
6. Barr BBB McLaren K Smith IW et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989 1 124 9.
7. Marks R Kolley D Lectas S. The risk of childhood exposure to sunlight in the development of solar keratoses and non-melanotic skin cancer. Med J Aust 1990 152 62 6.
8. Penn I. Posttransplant malignancies in pediatric organ transplant recipients. Transplat Proc 1994 26 2763 5.
9. Gupta AK Batra R Bluhm R et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004 51 785 98.
10. Moehrle M Dennenmoser B Schlagenhauff B et al. High prevalence of seborrhoeic dermatitis on the face and scalp in mountain guides. Dermatology 2000 201 146 7.
11. Abel EA. Cutaneous manifestations of immunosuppression in organ transplant recipients. J Am Acad Dermatol 1989 21 167 79.
12. London NJ Farmery SM Will EJ et al. Risk of neoplasia in renal transplant recipients. Lancet 1995 346 403 6.
13. Hartvelt MM Bouwes-Bavnick JN Koote A et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990 49 506 9.
14. Ferrandiz C Fumite MJ Ribera M et al. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995 33 590 6.
15. Hardie IR Strong RW Hartley LC et al. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980 87 177 83.
16. Jensen P Hansen S Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999 40 177 86.
17. Euvrard S Kanitakis J Pouteil-Noble C et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995 33 222 9.
18. Frezza EE Fung JJ van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997 44 1172 8.
19. Kelly DM Emre S Guy SR et al. Liver transplant recipients are not at an increased risk for nonlymphoid solid organ tumours. Cancer 1998 83 1237 43.
20. Levy M Backman L Husberg B et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993 25 1397 9.
21. Hojo M Morimoto T Maluccio M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999 397 530 4.
22. Boyle J Mackie RM Briggs JD et al. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984 1 702 5.
23. Jensen P Hansen S Moller B et al. Are renal transplant recipients on Cs-A based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone? Transplant Proc 1999 31 1120.
24. Bunney MH Benton EC Barr BB et al. The prevalence of skin disorders in renal allograft recipients receiving cyclosporin A compared with those receiving azathioprine. Nephrol Dial Transplant 1990 5 379 82.
25. Servill KS Burnham DK Daynes RA. Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumours in mice. Transplantation 1987 44 291 5.
26. Moore DE Sik RH Bilski P et al. Photochemical sensitisation by azathioprine and its metabolites. Part 3. A direct EPR and spin-trapping study of light-induced free radical from 6-mercaptopurine and its oxidation products. Photochem Photobiol 1994 60 574 81.
27. Dantal J Hourmant M Touraine JL et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cylcosporin regimens. Lancet 1998 351 623 8.
28. Bavinck JN De Boer A Vermeer BJ et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993 129 242 9.
29. Parrish JA. Ultraviolet radiation affects the immune system. Pediatrics 1983 71 129 33.
30. Harwood CA Surentheran T McGregor JM et al. Human papilloma virus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000 61 289 97.
31. Shamanin V zur Hausen H Lavergne D et al. Human papilloma virus infections in non-melanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996 88 802 11.
32. Purdie KJ Pennington J Proby CM et al. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J 1999 18 5359 69.